These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. Srinivasan V; Singh J; Pandi-Perumal SR; Brown GM; Spence DW; Cardinali DP Adv Ther; 2010 Nov; 27(11):796-813. PubMed ID: 20827520 [TBL] [Abstract][Full Text] [Related]
23. Circadian tau differences and rhythm associations in delayed sleep-wake phase disorder and sighted non-24-hour sleep-wake rhythm disorder. Micic G; Lovato N; Ferguson SA; Burgess HJ; Lack L Sleep; 2021 Jan; 44(1):. PubMed ID: 32619243 [TBL] [Abstract][Full Text] [Related]
24. Postoperative circadian disturbances. Gögenur I Dan Med Bull; 2010 Dec; 57(12):B4205. PubMed ID: 21122464 [TBL] [Abstract][Full Text] [Related]
25. Tasimelteon (Hetlioz™): A New Melatonin Receptor Agonist for the Treatment of Non-24-Hour Sleep-Wake Disorder. Bonacci JM; Venci JV; Gandhi MA J Pharm Pract; 2015 Oct; 28(5):473-8. PubMed ID: 25092604 [TBL] [Abstract][Full Text] [Related]
26. Tasimelteon for the treatment of non-24-hour sleep-wake disorder. Neubauer DN Drugs Today (Barc); 2015 Jan; 51(1):29-35. PubMed ID: 25685859 [TBL] [Abstract][Full Text] [Related]
27. A clinical approach to circadian rhythm sleep disorders. Barion A; Zee PC Sleep Med; 2007 Sep; 8(6):566-77. PubMed ID: 17395535 [TBL] [Abstract][Full Text] [Related]
28. Association between circadian disruption and diseases: A narrative review. Hou Y; Liu L; Chen X; Li Q; Li J Life Sci; 2020 Dec; 262():118512. PubMed ID: 33010281 [TBL] [Abstract][Full Text] [Related]
31. Disorders of the circadian clock: etiology and possible therapeutic targets. Wisor JP Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):555-66. PubMed ID: 12769597 [TBL] [Abstract][Full Text] [Related]
32. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Morgenthaler TI; Lee-Chiong T; Alessi C; Friedman L; Aurora RN; Boehlecke B; Brown T; Chesson AL; Kapur V; Maganti R; Owens J; Pancer J; Swick TJ; Zak R; Sleep; 2007 Nov; 30(11):1445-59. PubMed ID: 18041479 [TBL] [Abstract][Full Text] [Related]
33. Tasimelteon approved for circadian disorder in blind adults. Traynor K Am J Health Syst Pharm; 2014 Mar; 71(5):350. PubMed ID: 24534583 [No Abstract] [Full Text] [Related]
34. The Effect of Blindness on Biological Rhythms and the Consequences of Circadian Rhythm Disorder. Atan YS; Subaşı M; Güzel Özdemir P; Batur M Turk J Ophthalmol; 2023 Apr; 53(2):111-119. PubMed ID: 37089032 [TBL] [Abstract][Full Text] [Related]
35. Circadian Rhythm Disturbances in the Blind. Hartley S; Dauvilliers Y; Quera-Salva MA Curr Neurol Neurosci Rep; 2018 Aug; 18(10):65. PubMed ID: 30083814 [TBL] [Abstract][Full Text] [Related]
36. Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals. Keating GM CNS Drugs; 2016 May; 30(5):461-8. PubMed ID: 27003694 [TBL] [Abstract][Full Text] [Related]
37. Chronobiology of sleep in humans. Lack LC; Wright HR Cell Mol Life Sci; 2007 May; 64(10):1205-15. PubMed ID: 17364140 [TBL] [Abstract][Full Text] [Related]
38. A practical approach to circadian rhythm sleep disorders. Bjorvatn B; Pallesen S Sleep Med Rev; 2009 Feb; 13(1):47-60. PubMed ID: 18845459 [TBL] [Abstract][Full Text] [Related]
39. In vivo molecular chronotyping, circadian misalignment, and high rates of depression in young adults. Nguyen C; Murray G; Anderson S; Filipowicz A; Ingram KK J Affect Disord; 2019 May; 250():425-431. PubMed ID: 30878655 [TBL] [Abstract][Full Text] [Related]